ISPC
iSpecimen Inc.
$2.64
-0.09 (-3.30%)
At close · Jul 2
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued. Management’s plan to mitigate the conditions that raise substantial doubt includes generating additional revenues, deferring certain projects and capital expenditures and eliminating certain future operating expenses for the Company to continue as a going concern. However, there can be no assurance that the Company will be successful in completing any of these options. As a result, management’s plans cannot be considered probable and thus do not alleviate substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 18, 2026
Market Cap
$3.79M
Shares
1,437,157
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.64
Open$2.70
Day$2.60–2.96
52W$0.10–6.77
Avg vol 30d162K
Short int183K · 12.7% float · 1.7d
Short vol40%
Last earningsAug 6, 2024
DataJun 2021–Jul 2026
Filing10-Q · May 18
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+115% above
−
Price vs 50-day avg
−22% below
◦
RSI (14)
44 · neutral
+
MACD trend
positive
◦
52-week position
38% · mid-range
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $3 › 200d $1 — 50d above 200d
◦
Institutional flow
0% holders QoQ · +4 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
12.72% of float · ▼ -24.2% MoM · 1.7 days cover
◦
Volume signal
High volume on a down day — possible exhaustion
◦
Institution breadth
11 holders — mid 1-yr range
Fundamentals
Strong
−
Revenue growth
−79% Y/Y
+
EPS growth
+87% Y/Y
−
Free cash flow
$-4.2M
+
Valuation
P/E 0.1 · below peers
+
Balance sheet
net cash $3.5M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 18, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+115% above
Bullish
Price vs 50-day avg
−22% below
Bearish
RSI (14)
44 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
38% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $3 › 200d $1 — 50d above 200d
Institutional flow
Flat
0% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
12.72% of float · ▼ -24.2% MoM · 1.7 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
11 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $0
Now $3 · 38%
52-wk high $7
vs 200-day avg +115%
vs 50-day avg -22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ISPC
this stock
iSpecimen Inc.
|
$3.79M | +915.4% | -79.2% | 0.1 | 12.7% |
|
TMO
Thermo Fisher Scientific Inc.
|
$189.09B | -9.6% | +0.4% | 28.0 | 1.2% |
|
DHR
Danaher Corp /De/
|
$140.09B | -13.4% | +8.5% | 38.2 | 1.6% |
|
IDXX
Idexx Laboratories Inc /De
|
$44.00B | -17.5% | +10.4% | 41.0 | 2.7% |
|
NTRA
Natera, Inc.
|
$40.00B | +21.9% | -2.8% | — | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ISPC | +2.7% | -12.0% | +725.0% | -0.4% | +915.4% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +1.3% | -10.8% | +717.0% | -0.1% | +906.2% |